$BLIN

Bridgeline Digital (BLIN) Q3 2026 Earnings Call Transcript

Bridgeline Digital (BLIN) reported Q3 FY2026 results on an earnings call: total revenue $3.92M vs $3.88M prior year. Subscription revenue was $3.1M (79% of total). Core product revenue grew 13% to $2.4M, with core revenue mix at 62%. Net loss was $0.5M, improved from $0.8M. Cash was $1.5M at June 30, 2026.

Original reporting
Published Aug 14, 2026, 3:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 3:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Bridgeline Digital (BLIN) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$BLINBullishMed
01

Why it matters

The transcript highlights a shift in revenue mix toward core subscription revenue, improving retention and recurring revenue metrics, alongside continued margin pressure and ongoing cash discipline targets.

02

Market read

Traders can reassess BLIN’s growth quality and forward revenue composition based on reported core mix, NRR, ARR, and explicit fiscal 2027 mix projections.

03

What to watch

Cash balance is only $1.5M and adjusted EBITDA remains negative, so investors may scrutinize whether the company can sustain cash-neutral operations without dilutive financing as legacy revenue continues to attrit.

Relevance 7/10Novelty 6/10Timing: earnings call transcript released Aug. 14, 2026 (for quarter ended in Q3)

Background

Bridgeline is transitioning from legacy offerings toward its AI-powered search product HawkSearch, with management framing the business as a dedicated software company.

Company-level read

Ticker impact

$BLINBullishMedium confidence
Context

Bridgeline reported Q3 results and fiscal 2027 mix outlook, including core revenue mix over 70% and core subscription mix over 75%.

Expected impact

Near-term bias to the upside if investors focus on core mix shift, NRR above 100%, and improving adjusted EBITDA; downside risk if legacy attrition or cash burn re-accelerates.

Evidence & confidence

The article provides multiple decision-relevant datapoints: revenue composition, NRR, ARR, net loss improvement, adjusted EBITDA improvement, and explicit fiscal 2027 mix projections. However, it lacks full guidance ranges and detailed forward financials, limiting conviction on magnitude.

Market effects

Reinforces the market narrative that AI-powered search and discovery SaaS can command higher recurring revenue quality, potentially supporting peer sentiment in small-cap martech/AI SaaS.

No clear regional transmission beyond US small-cap tech sentiment.

Limited global relevance; story is company-specific with B2B commerce software focus.

Counterpoint

Core mix growth may be partly offset by declining services revenue and lower subscription gross margin, so headline ARR and NRR could mask deteriorating unit economics.

Key entities

  • Bridgeline Digital

    BLIN, reporting Q3 2026 results and discussing the HawkSearch-driven shift in revenue mix and fiscal 2027 composition.

  • Ari Kahn

    CEO who discussed core product momentum, legacy attrition expectations, and cash-neutral operating approach.

  • Thomas Windhausen

    CFO who introduced the call and financial highlights.

Related articles

$CRMDMed

CorMedix Q2 Earnings Call Highlights

CorMedix (NASDAQ:CRMD) reported Q2 revenue rising to $39.7M from $39.7M a year earlier, with 2026 including $66.1M DefenCath sales and $35.8M from the Melinta portfolio. Net income was $26.0M ($0.33 basic). It reaffirmed 2026 revenue guidance of $325M-$345M and raised adjusted EBITDA to $125M-$140M. REZZAYO supplemental NDA is planned for Q3 2026, with FDA action expected H1 2027.

$CLXMed

Are Wall Street Analysts Predicting Clorox Stock Will Climb or Sink?

The article says The Clorox Company (CLX) shares have lagged the S&P 500 over 52 weeks, down 13.7% versus SPX up 20.6%. After Q4 2026 results on Aug. 3, CLX rose 6.5% on $1.95B sales and adjusted EPS $1.66, plus FY2027 net sales growth guidance of 13%-14%. Analysts: consensus Hold, JPMorgan raised PT to $95; stock trades above the mean $96.94, with a Street-high $117.

$CDNSMed

CDNS Falls 12.9% in the Past Month. Is the Sell-Off an Opportunity?

Cadence Design Systems (CDNS) shares fell 12.9% over the past month despite Q2 results. According to the company, Q2 revenue rose 24.2% to $1.584B and non-GAAP EPS rose 27.9% to $2.11. The company raised 2026 guidance to $6.26-$6.34B revenue and $8.05-$8.15 EPS, with backlog at a record $8.1B. Valuation remains at 36.3x forward earnings.

$AIRTMedAI 8/10

Air T, Inc. Continues Track Record of Growth in First Quarter Fiscal 2027: Crestone Completes Acquisition of Arena

Air T, Inc. (NASDAQ:AIRT) reported fiscal 2027 first-quarter results for the period ended June 30, 2026. Revenue rose to $115.5 million, up 63% year over year, while operating loss widened to $12.8 million. Adjusted EBITDA was $0.8 million, down 45%. The company said results were pressured by acquisition and integration costs tied to Crestone’s Arena deal and non-cash depreciation from purchase accounting. Crestone acquired Arena Aviation Capital for $33.9 million.

$PRPOMed

Precipio, Inc. (PRPO): Results of Operations and Financial Condition

Precipio, Inc. (PRPO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2623274d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Precipio Announces Q2-2026 Financial Results Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens cash position NEW HAVEN, CT, Globenewswire – (Aug 14, 2026) - Specialty cancer